Jun 11
Three NGS sequencing companies have joined the 1000 Genomes Project
Leaders of the 1000 Genomes Project announced today that three firms that have pioneered development of new sequencing technologies have joined the international effort to build the most detailed map to date of human genetic variation as a tool for medical research. The new participants are: 454 Life Sciences/Roche, SOLiDApplied Biosystems and Solexa/Illumina Inc..
The three companies each have agreed to sequence the equivalent of 75 billion DNA bases in the program’s pilot phase, generating the equivalent of 25 human genomes each over the coming year, according to GenomeWeb.
Update: There is a nice piece on this over at the Genetic Future blog
